Home/Filings/4/0001062993-25-012406
4//SEC Filing

Sandler Laura Lee 4

Accession 0001062993-25-012406

CIK 0000907654other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 9:26 PM ET

Size

5.6 KB

Accession

0001062993-25-012406

Insider Transaction Report

Form 4
Period: 2025-07-01
Sandler Laura Lee
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-07-01+25,00025,000 total
    Exercise: $11.80Exp: 2035-06-30Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on July 1, 2026, and as to 1/48 of the underlying shares monthly thereafter.

Issuer

Oruka Therapeutics, Inc.

CIK 0000907654

Entity typeother

Related Parties

1
  • filerCIK 0002075401

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 9:26 PM ET
Size
5.6 KB